Even if the pathophysiology of both conditions is not fully elucidated and not identical, the role of an impaired intestinal barrier function and altered microbiota in the pathogenesis and progression of chronic liver disease is increasingly recognized as a key player
These may help your provider contextualize whether metabolic support, appetite-regulating peptides, or combination therapy aligns with your genetic predispositions and clinical biomarkers
They reviewed my prior labs instead of treating it like a generic wellness upsell
We can likely get this food back in, the microbiome just needs more time to repopulate and diversify before trying it again
BPC-157 is commonly discussed for chronic pain related to joint stress, connective tissue injuries, and inflammation
Archives of Biochemistry and Biophysics 277(2):337-344. [doi.org]